ClinicalTrials.Veeva

Menu

Effects of Lacticaseibacillus Rhamnosus LRa05 on Bacterial Vaginosis and Ovarian Function in Women

W

Wecare Probiotics

Status

Not yet enrolling

Conditions

Patients With Bacterial Vaginosis

Treatments

Dietary Supplement: Probiotic
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT06821789
WK2025004

Details and patient eligibility

About

In this study, Lacticaseibacillus rhamnosus LRa05 was selected as test preparations to observe the clinical efficacy in the intervention trial of combined antibiotic therapy, and to evaluate its effects on the cure rate, recurrence rate and vaginal microbiota of patients with bacterial vaginitis.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. 18 to 65 years old, sexual activity, premenopausal women;
  2. Nugent score for diagnosing BV ≥7;
  3. Signed informed consent.

Exclusion criteria

  1. Mixed vaginitis, such as vulvovaginal candidiasis (VVC), Trichomonas vaginalis (TV) infection, Chlamydia trachomatis (CT) infection or gonococcal vaginitis;
  2. history of systemic organic disease or psychiatric illness;
  3. Planning pregnancy, breastfeeding, menstruation;
  4. within 5 days of the onset of the disease, any antibiotics have been used;
  5. long-term use of contraceptives or immunosuppressants;
  6. Allergic constitution or hypersensitivity to known components of the study drug.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups, including a placebo group

Probiotic group
Experimental group
Description:
Conventional medication (ornidazole vaginal suppositories for 7 days) + 30B CFU/strip/day LRa05 (before meals);
Treatment:
Dietary Supplement: Probiotic
Placebo group
Placebo Comparator group
Description:
Conventional medication (ornidazole vaginal suppositories for 7 days) + maltodextrin, one strip/day (before meals);
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems